Volgende

Automatisch afspelen

The role of chemotherapy in Hodgkin lymphoma

0 Bekeken • 06/26/23
Delen
insluiten
administrator
administrator
abonnees
0

Yago Nieto, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of chemotherapy in Hodgkin lymphoma (HL) treatment, which is typically employed in combination with novel agents such as brentuximab vedotin or checkpoint inhibitors. However, Prof. Nieto highlights that frail patients may require alternative chemotherapy-free approaches. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen